February 20, 2018 / 12:16 PM / 3 months ago

BRIEF-Ionis Licences New Antisense Drug For Kidney Disease To Astrazeneca

Feb 20 (Reuters) - Ionis Pharmaceuticals Inc:

* IONIS LICENCES NEW ANTISENSE DRUG FOR KIDNEY DISEASE TO ASTRAZENECA

* IONIS PHARMACEUTICALS INC SAYS ‍IT HAS LICENSED IONIS-AZ5-2.5(RX) (AZD2373) TO GLOBAL, SCIENCE-LED BIOPHARMACEUTICAL COMPANY ASTRAZENECA​

* IONIS PHARMACEUTICALS INC - ‍IONIS WILL RECEIVE A $30 MILLION UPFRONT PAYMENT FROM ASTRAZENECA FOR IONIS-AZ5-2.5(RX)​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below